Clinical Trials Browser

Phase 1 × Injections, Subcutaneous × 90 days × Clear all

NCT06223516 2026-03-11

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma

NCT07260708 2025-12-19

Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers

Phase 1 Recruiting

Advanced Cancers